Phase 2 Study Shows Promising Results for Potential Mucus Clearance Drug
June 7, 2018
A new drug intended to make it easier to clear mucus from the lungs of people with cystic fibrosis showed promising results in a Phase 2 clinical trial. The drug, called SPX-101, blocks the overactive sodium channels that line CF lung cells.